Publications: FMT (10)
2022
El-Salhy M, Winkel R, Casen C, Hausken T, Gilja OH, Hatlebakk JG. Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation - PubMed (nih.gov) Gastroenterology. 2022 Jun 13:S0016-5085(22)00625-4. doi: 10.1053/j.gastro.2022.06.020. Epub ahead of print. PMID: 35709830.
El-Salhy M, Mazzawi T, Hausken T, Hatlebakk JG. The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms - PubMed (nih.gov). Scand J Gastroenterol. 2022 Apr 29:1-10. doi: 10.1080/00365521.2022.2064725. Epub ahead of print. PMID: 35486073.
El-Salhy M, Mazzawi T, Hausken T, Hatlebakk JG. Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation - PubMed (nih.gov). Neurogastroenterol Motil. 2022 Mar 18:e14353. doi: 10.1111/nmo.14353. Epub ahead of print. PMID: 35302268.
2021
El-Salhy M, Kristoffersen AB, Valeur J, Casen C, Hatlebakk JG, Gilja OH, Hausken T. Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome - PubMed (nih.gov). Neurogastroenterol Motil. 2021 Jun 18:e14200. doi: 10.1111/nmo.14200. Epub ahead of print. PMID: 34145677.
El-Salhy M, Casen C, Valeur J, Hausken T, Hatlebakk JG. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome - PubMed (nih.gov). World J Gastroenterol 2021; 27(18): 2219-2237 [DOI: 10.3748/wjg.v27.i18.2219]
Mazzawi T, El-Salhy M, Lied GA, Hausken T. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome - PubMed (nih.gov). Front Cell Infect Microbiol. 2021 May 12;11:524851. doi: 10.3389/fcimb.2021.524851. PMID: 34055657; PMCID: PMC8149964.
2020
Mazzawi T, Eikrem Ø, Lied GA, Hausken T. Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation - PubMed (nih.gov). Gastroenterol Res Pract. 2020;2020:3520686. Published 2020 Feb 4.
2019
El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study - PubMed (nih.gov). Gut. 2020;69(5):859-867.
El-Salhy M, Hausken T, Hatlebakk JGIncreasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS) - PubMed (nih.gov). Nutrients. 2019;11(6):1415. Published 2019 Jun 24.
2018
Mazzawi T, Lied GA, Sangnes DA, et al The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation - PubMed (nih.gov). PLoS One. 2018;13(11):e0194904. Published 2018 Nov 14.